Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

• Status: Not yet recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This clinical trial investigates the acceptability of electronic cigarettes (JUUL) for smoking cessation (quitting smoking) and the reduction of surgery-related complications in patients with newly diagnosed head, neck, or lung cancer. Smoking before surgery is associated with increased risk of complications during and after surgery. Electronic cigarettes are a type of special product that gives small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking. Stopping cigarette smoking before surgery may reduce the risk of complications during and after surgery in patients with head, neck, or lung cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ohio State University Comprehensive Cancer Center
• Collaborator: National Cancer Institute (NCI)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Newly diagnosed lung cancer subjects will be stages I-III non-small cell lung cancer (NSCLC) and head and neck cancer subjects will be stages I-IV squamous cell carcinoma (SCC).

• Current smokers of combustible cigarettes who smoke >= 4 days/week.

• Lung cancer patients planning to undergo wedge resection surgery for their index cancer.

• Head and neck cancer patients planning to undergo surgical resection of their index cancer or exploratory biopsies (tonsil cancer).

• Patients must intend to receive ongoing oncology care at Ohio State University [OSU] (i.e., their clinic visit is not a consultation/second opinion).

• Patients that are over the age of 21 years.

Exclusion Criteria:

• Patients who are cognitively unable to understand the consent form or participate in interviews.

• Patients with hearing impairments.

• Patients who are planning to use or are currently using cessation medication to help quit or reduce smoking.

• Patients who are currently using e-cigarettes.

• Patients undergoing surgery including lobectomy, pneumonectomy, tracheotomy, laryngectomy, or free flap surgery.

• Patients with contraindications to per oral intake.

• Lung cancer patients who are on home supplemental oxygen at baseline.

• Patients that have problems with dexterity that would impact electronic cigarette use.

• Patients under 21 years of age.

• Patients who don't speak and read English.

• Patients with histologies other than NSCLC, or squamous cell carcinoma of the head and neck.

• Patients with nasopharyngeal, thyroid, or gland cancers.

• Patients with inoperable tumors.

• Pregnant women.

• Prisoners.